Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-30 @ 2:34 AM
Study NCT ID:
NCT07493850
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-25
First Post:
2026-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals
Sponsor:
Circul'Egg
Organization:
Study Overview
Official Title:
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals
Status:
NOT_YET_RECRUITING
Status Verified Date:
2026-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical study is to evaluate the efficacy and tolerability of EMC-CAP-2025A, an eggshell membrane-based dietary supplement, on age-related skin parameters in healthy adults.
The main questions this study aims to answer are:
* Does daily supplementation with EMC-CAP-2025A improve facial wrinkles compared to placebo?
* Does EMC-CAP-2025A improve skin hydration, firmness, elasticity, texture, and overall skin quality?
* Is EMC-CAP-2025A well tolerated when taken daily for 60 days?
Researchers will compare EMC-CAP-2025A to a placebo to assess its effects on multiple skin parameters using objective instrumental assessments and participant self-evaluations.
Participants will:
* Be randomly assigned to receive either EMC-CAP-2025A or a placebo
* Take one capsule orally once daily for 60 days
* Attend scheduled study visits at baseline, Day 30, and Day 60 for instrumental skin assessments and safety evaluations
* Complete self-assessment questionnaires related to skin quality and product tolerability
The main questions this study aims to answer are:
* Does daily supplementation with EMC-CAP-2025A improve facial wrinkles compared to placebo?
* Does EMC-CAP-2025A improve skin hydration, firmness, elasticity, texture, and overall skin quality?
* Is EMC-CAP-2025A well tolerated when taken daily for 60 days?
Researchers will compare EMC-CAP-2025A to a placebo to assess its effects on multiple skin parameters using objective instrumental assessments and participant self-evaluations.
Participants will:
* Be randomly assigned to receive either EMC-CAP-2025A or a placebo
* Take one capsule orally once daily for 60 days
* Attend scheduled study visits at baseline, Day 30, and Day 60 for instrumental skin assessments and safety evaluations
* Complete self-assessment questionnaires related to skin quality and product tolerability
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| CTRI/2026/XXXXXX (Pending) | REGISTRY | CTRI | View |